BioMedical SIG #9

BioMedical SIG #9

Join the next BioMedical SIG webinar to discover The Venture Builder Model: Turning IP into Impact.

Book Your Place

This event has now expired

Turning groundbreaking biotech research into real-world solutions is often hindered by the infamous “valley of death” — the critical gap where funding is scarce, risk is high, and startups often fail to take shape. We will explore how the venture builder model can play a transformative role in bridging that gap and accelerating the path from lab bench to market.

In this session, we will discover:

  • Why the valley of death is especially deep in biotech — and what it takes to cross it
  • How venture builders provide the structure, resources, and expertise needed to de-risk academic IP
  • Case studies of successful biotech startups launched from university research
  • Practical strategies for TTOs to partner with venture builders and boost commercialization outcomes

This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.

Booking Options

  • Are you an ASTP Member?

  • By proceeding with this booking, you are agreeing to allow ASTP to use your image solely for promotional and educational purposes.

Testimonials

testimonial

ASTP has excellent courses to immerse yourself into the world of tech transfer.

Qing Cai

Vrije Universiteit Brussel, Belgium

testimonial

Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.

Koenraad Debackere

KU Leuven, Belgium

testimonial

Working and Learning with old and new friends – best way to do it!

Sara Matt-Leubner

University of Innsbruck, Austria

testimonial

Most experienced technology transfer crew in the Europe.

Krzysztof Maternicki

Jan Dlugosz University, Poland

testimonial

The course Software Specific Challenges is a must for every TTO/KTO professional, especially for those working with Social Sciences and Humanities!

Brechtje Vreenegoor

Radboud University, Netherlands